Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry
María O. López-Oliva, Isabel Pérez-Flores, María Molina, María José Aladrén, Hernando Trujillo, Dolores Redondo-Pachón, Verónica López, Carme Facundo, Florentino Villanego, Marisa Rodríguez, Maria Carmen Ruiz, Paula Antón, Alba Rivas-Oural, Sheila Cabello, José Portolés, Lourdes de la Vara, Guadalupe Tabernero, Rosalía Valero, Cristina Galeano, Esperanza Moral, Ana Ventura, Armando Coca, Miguel Ángel Muñoz, Román Hernández-Gallego, Amir Shabaka, Gabriel Ledesma, Hanane Bouarich, María Ángeles Rodríguez, Lourdes Pérez Tamajón, Leónidas Cruzado, José Emilio Sánchez, Carlos Jiménez
10.1016/j.nefroe.2023.08.004
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio
Anna Vidal-Alabró, Helena Colom, Pere Fontova, Gema Cerezo, Edoardo Melilli, Nuria Montero, Ana Coloma, Anna Manonelles, Alex Favà, Josep M. Cruzado, Joan Torras, Josep M. Grinyó, Nuria Lloberas
10.1016/j.nefroe.2024.03.019